๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The Impact of Local and Regional Disease Extent on Overall Survival in Patients With Advanced Stage IIIB/IV Non-Small Cell Lung Carcinoma

โœ Scribed by Daniel S. Higginson; Ronald C. Chen; Gregg Tracton; David E. Morris; Jan Halle; Julian G. Rosenman; Mihaela Stefanescu; Erica Pham; Mark A. Socinski; Lawrence B. Marks

Book ID
118457391
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
414 KB
Volume
84
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The impact of age on toxicity, response
The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel
โœ Thomas A. Hensing; Amy H. Peterman; Michael J. Schell; Ji-Hyun Lee; Mark A. Soci ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND The optimal treatment strategy for elderly patients with advanced nonsmall cell lung carcinoma has not been defined to date. The authors performed a retrospective analysis of a Phase III trial that treated patients who had Stage IIIB or IV nonsmall cell lung carcinoma wit

Impact of staging transesophageal EUS on
Impact of staging transesophageal EUS on treatment and survival in patients with non-small-cell lung cancer
โœ Mohamad A. Eloubeidi; Renee Desmond; Shilpa Desai; Mohit Mehra; Ayesha Bryant; R ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 315 KB

## Background: Transesophageal eus-guided fna (eus-fna) is safe, accurate, and cost effective in staging patients with non-small-cell lung cancer (nsclc). however, the impact of eus-fna on patient survival has not been demonstrated. ## Objective: To determine the impact of metastatic disease in m